CDKN2B and cervical carcinoma: In the present study, we showed that CDKN2B‐AS1 was overexpressed in cervical cancer and it might play an oncogenic role in promoting malignancy of cervical cancer cells, including proliferation promotion, apoptosis inhibition, and senescence inhibition.